“Study of the Association between Plasminogen Activator Inhibitor-1, other Inflammatory Markers, Metabolic Control Parameters, and Diabetic Foot Disease” (2022) Biomedical Research and Therapy, 9(3), pp. 4986–4995. doi:10.15419/bmrat.v9i3.733.